Timolol
(2S)-1-(tert-Butylamino)-3-[(4-morpholin-4-yl-1,2,5-thiadiazol-3-yl)oxy]propan-2-ol
Drag to rotate. Structure from PubChem CID 33624.
Background
Listing
- Schedules
- Schedule 3
- Source
- Consolidated Schedules 06 July 2026
Registered medicines
12 registered products listed
Counted through the register's ingredient index, which does not reach every record.
| Name | Brands | Dosages | Applicants | Registrations | Schedule |
|---|---|---|---|---|---|
| Timolol | Glaucosan, Glaucobex, Timoptol-xe, +8 more | 0,1%, 0,25%, 0,25 %, 0.5 %, +5 more | 8 applicants | 17 registrations | S3 |
| Dorzolamide, timolol | Cosopt, Glauopt co, Dorzotim, +14 more | 20/5 mg, 20 mg/ml + 5 mg/ml, drops, 20 mg, 5 mg | 14 applicants | 17 registrations | S3 |
| Latanoprost, timolol | Xalacom, Co-atana ophthalmic, Oculatim, +9 more | 5 mg/mL, solution, 50 μg/mL and 5 mg/mL, drops | 8 applicants | 12 registrations | S4 |
| Bimatoprost, timolol | Ganfort, Bimagam fort, Bimapres fort, +7 more | 0,3 mg/ml, 0,3 mg/mL and 5 mg/mL, 5 mg, 0,3 mg | 5 applicants | 10 registrations | S4 |
| Brinzolamide, timolol | Azarga | Not stated | Novartis South Africa (Pty) Ltd | 440046 | S3 to S4 |
| Latanoprost 50 0 g, timolol | Comarestol | 50 µg/ 5 mg/ml | Ipharma (Pty) Ltd | 490155 | S4 |
| Brimonidine, timolol | Brimoct co, Combigan | 2 mg/ml + 5 mg/ml | 2 applicants | 2 registrations | S3 to S4 |
| Timolol, travoprost | Ocutra, Mytramtil eye, Opituran, +1 more | drops solution, drops | 4 applicants | 4 registrations | S3 to S4 |
| Dorzalomide, timolol | Adortim, Optitrin, Glauspec | 20 mg, 5 mg | Trinity Pharma (Pty) Ltd | 3 registrations | S3 |
| Timolol, tranvoprost | Ravtagon forte | Not stated | Austell Pharmaceuticals (Pty) Ltd | 560727 | S3 to S4 |
| Dorzolamide20, timolol | Dorzolamide/timolol eye FDC | drops | FDC SA (Pty) Ltd | 561209 | S3 to S4 |
| Amiloride, hydrochlorothiazide, timolol | Servatrin | 2.5mg | Pharmacare limited û woodmead | V0354 | S3 |
Regulatory status
Where S3 sits on the scale
Needs a doctor's prescription, dispensed by a pharmacist.
Schedule 3 medicines can only be sold on a prescription from an authorised prescriber, such as a doctor or dentist. A pharmacist dispenses the medicine once they have the written prescription, or a verbal instruction from a prescriber they know. Its price, name, pack size and strength can still be told to the public, as long as nothing links it to what it treats.
Schedule S3, as the Consolidated Schedules list it.
Who may supply: A pharmacist dispensing against a written or verbal prescription from an authorised prescriber; a veterinarian, who may also prescribe, compound or dispense it directly; a medical practitioner or dentist, who may prescribe it and may compound or dispense it directly only if licensed under section 22C(1)(a); manufacturers and wholesalers may supply people who may lawfully possess it; and, for animal treatment, a person practising a para-veterinary profession, on a veterinarian's written or verbal instruction.
Consolidated Schedules listings for Timolol
S3: Timolol
Consolidated Schedules 06 July 2026, line 4325
This is an informational summary of the Medicines and Related Substances Act 101 of 1965 and its 2017 General Regulations. It is not medical advice and not legal advice. Always check the medicine's label, which carries the schedule number inside a square border, or ask a pharmacist if you are unsure.